How Is Moderna's Stock Performance Compared to Other Healthcare Stocks? Moderna, Inc. 's rapid ascent in the past year has raised questions about its long term prospects. With a market capitalization of $58.
1 billion and notable milestones such as its personalized mRNA cancer vaccine, it is easy to get swept up in the hype surrounding this biotechnology company.
The Biotech Bubble Moderna's surge is part of a broader trend in the biotechnology industry, where innovative companies are attracting massive investments from Wall Street.